Please login to the form below

Not currently logged in
Email:
Password:

Chinese 2006 R&D spend exceeds USD 39.9bn

China invested CNY 300.3bn in R&D in 2006 to augment science and technology innovation and develop a more sustainable economy

China invested CNY 300.3bn (USD 39.9bn) in R&D in 2006 to augment science and technology innovation and develop a more sustainable economy, according to local media reports.

The Chinese government has set the target of investing two per cent of its GDP in R&D by 2010, as set out in the 11th Five-Year Programme for National Economic and Social Development (2006 to 2010).

R&D investment rose by an annual rate of 22.6 per cent, or CNY 55.3bn, according to a statement released by the National Bureau of Statistics, the Ministry of Science and Technology and the Ministry of Finance on 12 September.

R&D spending accounted for 1.4 per cent of GDP and was the highest proportion ever recorded in the region. R&D spending by companies reached the CNY 213.5bn mark and accounted for 71.1 per cent of the total.

Government research agencies spent CNY 56.7bn, while universities spent CNY 27.7bn, (18.9 and 9.2 per cent).

Approximately CNY 234.3bn, or 78 per cent of China's total R&D spending went on development work, but only 16.8 per cent went on application research and 5.2 per cent went on basic scientific research.

The pharmaceutical, special instruments, electrical machinery, general instruments, transport manufacturing, rubber and electronics sectors spent more than one per cent of their sales revenues on R&D.

The Chinese government has ring-fenced CNY 168.9bn for science and technology front, an increase of 26.5 per cent (CNY 35.4bn) on 2005. The amount was 4.2 per cent of the government's total expenditure in 2006, the highest since 1998.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics